Pharmena (WAR:PHR) Short Interest


WAR:PHR Pharmena SA WAR:PHR
56 GF Score
Price zł3.08
GF Value zł5.78
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Pharmena Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

WAR:PHR vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Pharmena's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmena Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmena's Short Interest distribution charts can be found below:

* The bar in red indicates where Pharmena's Short Interest falls into.


WAR:PHR
56GF Score
Pharmena SA WAR:PHR
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pharmena (WAR:PHR) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmena stock appears to be undervalued. The current stock price of zł3.08 is trading 46.7% below its estimated GF Value™ of zł5.78. GuruFocus considers Pharmena to be Possible Value Trap.

Key valuation signals for WAR:PHR:

  • Short Interest:
  • GF Value™: zł5.78 vs. price of zł3.08 (46.7% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the WAR:PHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmena Business Description

Address Ulica Wolczanska 178, Lodz, POL, 90-530
Pharmena SA produces cosmeceuticals and pharmaceuticals. The company's activity focuses on three areas such as research in the USA and Canada on the application of selected pyridinium salts in medicine in order to develop an anti-atherosclerosis drug on a global scale, Production and sales of innovative patented dermocosmetics and introduction into the market of an innovative dietary supplement for atherosclerosis prophylaxis. Its products include Menavitin, Dermena, Allerco and Thermi.
56GF Score

Get the complete analysis for WAR:PHR

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.08
Price
zł5.78
GF Value